A critical review of clinical trials in systemic lupus erythematosus.
about
Targeting CD22 with the monoclonal antibody epratuzumab modulates human B-cell maturation and cytokine production in response to Toll-like receptor 7 (TLR7) and B-cell receptor (BCR) signalingSystemic lupus erythematosus: Extent and patterns of off-label use of rituximab for SLE.New Perspectives in Rheumatology: Biomarkers as Entry Criteria for Clinical Trials of New Therapies for Systemic Lupus Erythematosus: The Example of Antinuclear Antibodies and Anti-DNA.New Perspectives in Rheumatology: May You Live in Interesting Times: Challenges and Opportunities in Lupus Research.
P2860
A critical review of clinical trials in systemic lupus erythematosus.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
A critical review of clinical trials in systemic lupus erythematosus.
@en
type
label
A critical review of clinical trials in systemic lupus erythematosus.
@en
prefLabel
A critical review of clinical trials in systemic lupus erythematosus.
@en
P2093
P2860
P356
P1433
P1476
A critical review of clinical trials in systemic lupus erythematosus.
@en
P2093
M A Mahieu
P E Lipsky
R Ramsey-Goldman
P2860
P304
P356
10.1177/0961203316652492
P577
2016-09-01T00:00:00Z